AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Archives: News
Is Open Data the Silver Bullet for Better Drugs?
Open data sharing within the pharmaceutical industry is crucial for opening the floodgates of innovation. Successful innovation depends on having a rich supply of high-quality data because, without the right kind and quantity of data, there wouldn’t be a foundation for the research required to innovate. The best way to achieve this critical mass of …
Is Open Data the Silver Bullet for Better Drugs? Read More »
New Blockchain and AI-based Platform to Revolutionize Drug Discovery
Innoplexus aims to democratize drug development with launch of new iPlexus Eschborn, Germany: Innoplexus AG announced today a groundbreaking update coming soon to their iPlexus platform that will leverage the power of blockchain technology and artificial intelligence to resolve inefficiencies in early-stage drug discovery. With an expected launch date of June 30, 2018, the new …
New Blockchain and AI-based Platform to Revolutionize Drug Discovery Read More »
How Blockchain leverages the Power of Failure in Drug Development for the benefit of the patient
2.5 quintillion bytes of data are created every day. The challenge is to identify the relevant ones for solving a challenging question. That is where Artificial Intelligence solutions and blockchain can help make this knowledge public. If a beloved family member or close friend becomes seriously ill, you want the best treatment and cure for …
Innoplexus’s New North American Affiliate is Bringing AI Innovation to the US Pharma Industry
It’s no secret that the American pharma industry is facing its fair share of challenges. From rising drug prices to corruption charges, the issues that American pharmaceutical companies face today demand innovative solutions. Fortunately, a leading pharmaceutical innovation company is hoping to deliver these solutions with the launch of their North American affiliate. Innoplexus AG …
Innoplexus Releases New Study Examining Consumer Perceptions of Pharmaceutical Companies
Insights are intended to guide innovations and reforms within the industry Hoboken, New Jersey: Innoplexus, a leader in artificial intelligence and data analytics solutions for pharmaceutical and life science research, announced today the publication of a new study examining consumer perceptions about drug prices, transparency, and other issues related to the pharmaceutical industry. This survey …
Innoplexus Releases New Study Examining Consumer Perceptions of Pharmaceutical Companies Read More »
Innoplexus supports the European Summer School in Logic, Language and Information
In late 90s, internet solved the problem of data access. Then came the explosion of data with the web search and social media. Necessity to find relevant data & analyse it in specific context gave birth to the new field of science, the data sciences. The inter-disciplinary fields spans software development, data persistence & warehousing, …
Innoplexus supports the European Summer School in Logic, Language and Information Read More »
Innoplexus Announces New North American Affiliate Helmed by Former Merck KGaA Executive
Leader in Pharmaceutical Research AI expands North American Presence. HOBOKEN, NJ, May 10, 2018 /24-7PressRelease/ — Innoplexus, a leader in artificial intelligence and data analytics solutions for pharmaceutical and life science research, announced today the opening of Innoplexus Americas. This new affiliate will focus on empowering pharmaceutical companies in the United States and Latin America to achieve new …
Innoplexus Announces New North American Affiliate Helmed by Former Merck KGaA Executive Read More »
Innoplexus supports the WHO “Save Lives – Clean Your Hands” -Campaign 2018 with AI technology
Eschborn, 5th May 2018 – Innoplexus AG supports the World Health Organization (WHO) and the Global Sepsis Alliance (GSA) by measuring the effect of its online and social media communication initiatives using its Artificial Intelligence (AI) based analysis technologies. Annually on May 5th, 20’000 hospitals across 177 countries participate in promoting hygiene standards worldwide. This …
Why Amazon Needs AI At The Center Of Its Healthcare Strategy Forbes Technology Council
Post Written ByGunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. In December 2017, Amazon, JPMorgan Chase and Berkshire Hathaway announced the formation of a new healthcare company which would use technology to provide high-quality healthcare to patients and families more simply, and at a more reasonable cost. This move and rumors …
Why Amazon Needs AI At The Center Of Its Healthcare Strategy Forbes Technology Council Read More »